CBD oil might be on the menu for drug stores soon, while the public service is recommended to do definitely nothing on social media. Overtake the news you might have missed out on.
There was some quite big news in the Drug Store Daily e-mail blast on Wednesday September 9. If it’s still suffering unread in your inbox then please be recommended that the Restorative Product Administration has actually supposedly made an interim choice to class cannabidiol(CBD) as a Schedule 3 drug since February 1 next year.
Arrange 3 means it’s offered at pharmacists’ discretion without a prescription– you understand, like specific type of pain relievers and cold ‘n’ flu tablets, or Ventolin.
And just in case anybody’s about to toss their hands up about how our area chemists are about to end up being the demented piano party from Reefer Insanity, note that this still means Australia has a few of the planet’s strongest restrictions on access to cannabis-derived medication. Also, simply to be clear, the stuff is not going to get you high because there’ll be little-to-no THC in it.
About the Author
Andrew P Street is a Sydney-built, Adelaide-based author and journalist.